1-1 of 1
Martine C. J. Abrahamse-Testroote
Close
Sort by
Journal Articles

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL

Clinical Trials & Observations
Christian H. Geisler, Mars B. van t’ Veer, Jesper Jurlander, Jan Walewski, Geir Tjønnfjord, Maija Itälä Remes, Eva Kimby, Tomas Kozak, Aaron Polliack, Ka Lung Wu, Shulamiet Wittebol, Martine C. J. Abrahamse-Testroote, Jeanette Doorduijn, Wendimagegn Ghidey Alemayehu, Marinus H. J. van Oers
Journal: Blood
Blood (2014) 123 (21): 3255–3262.
https://doi.org/10.1182/blood-2014-01-547737
Published: 2014
Includes: Supplemental data